[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2017-2021 France Nucleic Acid Testing/NAT Market: Growth Opportunities and Business Expansion Strategies for Instrument and Reagent Suppliers

February 2017 | 1125 pages | ID: F45D9F47488EN
Venture Planning Group

US$ 6,030.00 US$ 6,700.00 -10 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Highlights
  • Comprehensive 1,125-page market segmentation analysis of the French NAT market.
  • Major issues pertaining to the French NAT laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.
  • An extensive review of DNA probe and biochip technologies, test formats, detection methodologies, trends in testing automation and amplification methods.
  • Five-year test volume and reagent sales forecasts for the following categories:
- Infectious Diseases - Cancer - Forensic Testing - Genetic Diseases - Paternity Testing/HLA Typing
  • Review of testing methodologies and instrumentation technologies.
  • Feature comparison of automated and semiautomated analyzers.
  • Sales and market shares of leading suppliers.
  • Over 60 specific opportunities for NAT instruments, test systems, IT and auxiliary products.
  • Profiles of major suppliers, and emerging market entrants, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
  • Alternative market penetration strategies.
  • Potential market entry barriers and risks.
  • Business planning issues and concerns.
Contains 1,125 pages and 58 tables
I. INTRODUCTION

II. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES

A. Instrumentation
B. Reagent Kits and Test Systems/panels
C. Computers, Software and Automation
D. Auxiliary Products

III. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS

IV. ALTERNATIVE MARKET PENETRATION STRATEGIES

A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies For Decentralized Testing Markets

V. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge And Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
VI. Worldwide Market and Technology Review
A. DNA Sequencing
  1. INTRODUCTION
  2. SEQUENCING METHODS
  3. AUTORADIOGRAPHY
  4. THE HUMAN GENOME PROJECT
  5. SEQUENCING AUTOMATION
  6. IMAGE SCANNERS
  7. FLUORESCENT DETECTION
  8. GENE PROFILING
  9. GENE EXPRESSION
  10. POLYMORPHISM SCREENING
  11. PROTEIN INTERACTION NETWORKS
B. DNA and RNA Probe Technologies
  1. BASIC PRINCIPLES
  2. PROBE PREPARATION
  3. THE DNA PROBE TEST
  4. TEST FORMATS
  5. LABELING TECHNIQUES
  6. AMPLIFICATION METHODS
C. Detection Technologies
  1. RADIOACTIVE METHODS
    a. Overview
    b. Major Isotopes
      P32
      S35
      H3
      I125

  2. NONISOTOPIC METHODS
    a. Enzymatic Labels
    b. Chemical Labeling
      Indirect Chemical Labeling
      Direct Chemical Labeling
    c. Fluorescence
    d. Chemiluminescence
    e. Electrical Conductivity
D. Molecular Diagnostic Instrumentation Review
  1. ABBOTT LCX
  2. BECKMAN COULTER/BIOMEK FK
  3. BD VIPER SYSTEM WITH XTR TECHNOLOGY
  4. BD INNOVA
  5. BECTON DICKINSON SDA
  6. BIOMERIEUX NUCLISENS EASYMAG
  7. BIOMERIEUX NUCLISENS EASYQ AND MINIMAG
  8. BIORAD GENESCOPE
  9. CEPHEID GENEXPERT
  10. CURETIS UNYVERO
  11. GENMARK DX ESENSOR XT8
  12. HOLOGIC/GENPROBE PANTHER
  13. HOLOGIC/GENPROBE TIGRIS/DTS
  14. HTG MOLECULAR EDGE
  15. LIFE TECHNOLOGIES QUANTSTUDI      DX
  16. QIAGEN QIASYMPHONY RGQ
  17. ROCHE COBAS AMPLICOR
  18. ROCHE COBAS TAQMAN
  19. ROCHE COBAS TAQMAN
  20. ROCHE COBAS TAQMAN AMPLIPREP
  21. ROCHE LIGHCYCLER
  22. ROCHE COBAS 4800
  23. ROCHE COBAS S
  24. SIEMENS VERSANT
  25. TECAN LS SERIES
E. Biochips: Genosensors, Microarrays, and LabsontheChip
Liquid Transportation and Mixing
Separation
Reaction
Detection
F. Pharmacogenomics
G. Major Applications
  1. MICROBIOLOGY/INFECTIOUS DISEASES
    a. Overview
    b. Major Infectious Diseases
      AIDS: HIV/HIV1/2/Combo, HIVAg/HIV NAT, Western Blot, HTLVI/II
      Adenovirus
      Aeromonas
      Anthrax/Bacillus Anthracis
      Arboviruses
      Babesiosis
      Bacillary Epithelioid Angiomatosis (BEA) and Other Bartonella (Rochalimaea)
      Blastocystis Hominis
      Brucella
      Campylobacter
      Candida
      Chagas Disease
      Chancroid
      Chlamydia
      Clostridium Difficile
      Coronaviruses
      Coxsackieviruses
      CreutzfeldtJakob’s Disease
      Cryptosporidium Parvum
      Cyclospora Cayetanensis
      Cytomegalovirus
      Ebola Virus
      E. Coli
      EchoVirus
      Encephalitis
      Enteroviruses
      EpsteinBarr Virus
      Giardia Lamblia
      Gonorrhea
      Granuloma Inguinale
      Hantavirus
      Helicobacter Pylori
      Hepatitis: HAV NAT, HBV NAT, HBs Ag, HCV, HCV NAT, AntiHBc, AntiHBs, AntiHAV, Hepatitis Delta, HBc Ag, HBe Ag, ALT/SGPT
      Herpes Simplex Virus
      HUMAN HERPES VIRUS6 (HHV6)
      Influenza Viruses
      Legionella
      Lyme Disease
      Lymphogranuloma Venereum (LGV)
      Malaria
      Measles (Rubeola)
      Meningitis
      Microsporidium
      Mononucleosis
      Mumps
      Mycoplasma
      Papillomaviruses
      Parvovirus B19
      Pneumonia
      Polyomaviruses
      Pseudomonas Aeruginosa
      Rabies
      Respiratory Syncytial Virus (RSV)
      Rhinoviruses
      Rotavirus
      Rubella
      Salmonellosis
      Septicemia
      Shigellosis
      Staphylococcus Aureus
      Streptococci
      Syphilis
      Toxoplasmosis
      Trichomonas Vaginalis
      Tuberculosis
      Vibrio
      West Nile Virus
      Yersina
  2. CANCER TESTING
    a. Overview
    b. Major Cancer Types
      Prostate
      Lung
      Colon and Rectum
      Breast
      Skin
      Uterine
      Leukemia
      Oral
    c. Oncogenes
      Abl/ablbcr
      AIB1
      BCL2
      BRCA1
      CD44

      Cfos
      Cmyb
      Cmyc
      CYP17
      ErbB
      HPC1
      Nmyc
      P40
      P51
      P53
      PIK3CA
      PTI1
      Ras
      Reg
      Sis
      Src
  3. GENETIC DISEASES
    a. Overview
    b. Nucleic Acid Amplification
    c. Chromosome Imaging
    d. Genomics Technologies
    e. Proteomics Technologies
    f. Current Pharmacogenomic Tests
    g. Future Pharmacogenomic Testing
    h. Major Diseases
      Achondroplasia
      Autosomal Dominant Polycystic Kidney
Disease
      Cancer
      Cosmetogenomics
      Cystic Fibrosis
      Down's Syndrome
      Duchenne and Becker Muscular Dystrophy
      Factor V (Leiden)
      Factor IX Deficiency
      Fragile X Syndrome
      Heart Disease
      Hemochomatosis
      Hemophilia
      Huntington's Disease
      MaternalFetal Incompatibility
      Multiple Endocrine Neoplasia
      Phenylketonuria (PKU)
      Polycystic Kidney Disease (PKD)
      Prenatal Screening
      Retinitis Pigmentosa
      Retinoblastoma
      Sickle Cell Anemia
      Spinal Muscular Atrophy
      Vitamin B12 Metabolism
    i. Social Issues and Concerns
  4. FORENSIC TESTING
    a. Overview
    b. Multilocus and Single Locus Probes
      Multilocus Probes
      Single Locus Probes
      PCR and RFLP
    c. The FBI
    d. DNA Profile Data Banks
      U.S.A.       U.K.     e. Judicial Implementation
    f. Major Crime Categories
    g. Factors Contributing to the DNA Probe
Market Expansion
      Technology Availability
      Use of Hair as Evidence
    h. Wildlife Forensics
  5. PATERNITY TESTING/HLA TYPING
  6. OTHER APPLICATIONS
    a. Disease Susceptibility Testing
    b. Cardiovascular Diseases
    c. Diabetes
    d. Alzheimer's Disease
    e. Periodontal Disease
    f. Plasma Purification
    g. Organ Transplantation
    h. Water Contamination
    i. Other
H. Competing/complementing
  1. MONOCLONAL ANTIBODIES/IMMUNOASSAYS
  2. RNA PROBES
  3. TWODIMENSIONAL ELECTROPHORESIS
  4. FLOW CYTOMETRY
VII. France Molecular Diagnostics Market
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts, Major Supplier Sales and Market Shares VIII. COMPETITIVE ASSESSMENTS
Abbott
Affymetrix
Agilent Technologies
Applied Gene Technologies
Arca Biopharma
Beckman Coulter/Danaher
Becton Dickinson
Biokit
bioMerieux
BioRad
Biotest
Cepheid
CellMark Forensics/LabCorp
Decode Genetics
Diadexus
Eiken
Elitech Group
Enzo
Exact Sciences
Fujirebio
Grifols
Hologic/GenProbe
Illumina
Kreatech/Leica
LiCor Biosciences
Monogram Biosciences/LabCorp
Myriad Genetics
OrthoClinical Diagnostics
Perkin Elmer/Caliper
Proteome Sciences
Qiagen
Roche
Scienion
Sequenom
Shimadzu
Siemens
Sierra Molecular
Takara Bio
Tecan Group
Thermo Fisher
XIII. Appendix: Major Universities and Research Centers
Developing Molecular Diagnostic Technologies

LIST OF TABLES

Major Companies Developing or Marketing AIDS Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Adenovirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Bartonella Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Campylobacter Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Candida Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Chlamydia Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Clostridium Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Coronavirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Cryptosporidium Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing CMV Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Echovirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Enterovirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing EBV Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Giardia Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Gonorrhea Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Hantavirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Helicobacter Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Hepatitis Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Herpes Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Influenza Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Legionella Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Lyme Disease Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Measles Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Meningitis Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Mononucleosis Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Mumps Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Mycoplasma Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Pneumonia Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing RSV Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Rotavirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Rubella Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Salmonella Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Septicemia Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Shigella Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Streptococci Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Syphilis Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Toxoplasmosis Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Trichomonas Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Tuberculosis Molecular Diagnostic and Other Direct Identification Tests
Oncogenes Potential Application in Cancer Diagnosis
Major Companies Developing or Marketing Cancer Molecular Diagnostic Tests
Major Companies Developing or Marketing Molecular Diagnostic Tests For Genetic Diseases
France Molecular Diagnostics Test Volume And Sales By Major Application 20142019
France Laboratories Performing DNA Sequencing By Market Segment 2014
France Molecular Diagnostics Market
Potential Laboratory Universe by Market Segment 2014
France Molecular Diagnostics Test Volume By Major Application 20142019
France Major Infectious Disease Test Volume by Assay 20142019
France Major Infectious Disease Test Volume by Method 2014
France Molecular Diagnostics Market By Major Application 20142019
France Molecular Diagnostics Market
Estimated Sales And Market Shares of Major Suppliers 2014
France Major Infectious Disease Diagnostics Market by Assay 20142019
France AIDS Testing Market Estimated Sales by Major Supplier 2014
France Adenovirus Testing Market Estimated Sales by Major Supplier
France Chlamydia Testing Market Estimated Sales by Major Supplier
France CMV Testing Market Estimated Sales by Major Supplier
France Gonorrhea Testing Market Estimated Sales by Major Supplier
France Hepatitis Testing Market Estimated Sales by Major Supplier
France Hepatitis C Testing Market Estimated Sales by Major Supplier
France HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier
France Herpes Testing Market Estimated Sales by Major Supplier
France Influenza Testing Market Estimated Sales by Major Supplier
France Meningitis Testing Market Estimated Sales by Major Supplier
France Mycoplasma Testing Market Estimated Sales by Major Supplier
France RSV Testing Market Estimated Sales by Major Supplier
France Shigella Testing Market Estimated Sales by Major Supplier


More Publications